Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: A decade in review

Psychopharmacology

Volumn 156, Issue 2-3, 2001, Pages 117-154

  Geyer, M A ^a   Krebs Thomson, K ^a   Braff, D L ^a   Swerdlow, N R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Animal; Prepulse inhibition; Rat; Schizophrenia; Startle

Indexed keywords

2 DIPROPYLAMINO 5 METHOXY 1 METHYLTETRALIN; 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 3 [[4 (4 CHLOROPHENYL) 1 PIPERAZINYL]METHYL] 1H PYRROLO[2,3 B]PYRIDINE; 3 ALLYL 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 3 BROMO N [(1 ETHYL 2 PYRROLIDINYL)METHYL] 6 METHOXYSALICYLAMIDE; 3,4,4A,10B TETRAHYDRO 4 PROPYL 2H,5H [1]BENZOPYRANO[4,3 B][1,4]OXAZIN 9 OL; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; AMANTADINE; AMPHETAMINE; APOMORPHINE; BROMOCRIPTINE; COCAINE; DOMPERIDONE; ETICLOPRIDE; HALOPERIDOL; N [(1 ETHYL 2 PYRROLIDINYL)METHYL] 3 IODO 5,6 DIMETHOXYSALICYLAMIDE; NEUROLEPTIC AGENT; PERGOLIDE; QUINELORANE; QUINPIROLE; RACLOPRIDE; REMOXIPRIDE; RESERPINE; ROPINIROLE; SEROTONIN AGONIST; SPIPERONE; SULPIRIDE; TETRABENAZINE; UNINDEXED DRUG; VANOXERINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ATTENTION; CHANNEL GATING; COGNITION; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC TRANSMISSION; DRUG EFFECT; DRUG SCREENING; NONHUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL; RAT; REVIEW; SCHIZOPHRENIA; SENSORIMOTOR FUNCTION; SEROTONIN RELEASE; STARTLE REFLEX;

ANIMALS; HUMANS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; STARTLE REACTION;

EID: 0034917841     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130100811     Document Type: Review

References (215)

1. 2 dopamine receptors in prepulse inhibition of the startle reflex in man
2. Effects of bromocriptine and haloperidol on prepulse inhibition: Comparison of the acoustic startle eyeblink response and the N1/P2 auditory-evoked response in man
3. Nicotine modulates effects of stress on acoustic startle reflexes in rats: Dependence on dose, stressor and initial reactivity
4. Nicotine increases sensory gating measured as inhibition of the acoustic startle reflex in rats
5. Strain and age differences in acoustic startle responses and effects of nicotine in rats
6. Effects of the PCP analog dizocilpine on sensory gating: Potential relevance to clinical subtypes of schizophrenia
7. Antagonism of phencyclidine-induced deficits in prepulse inhibition by the putative atypical antipsychotic olanzapine
8. Phencyclidine-induced deficits in prepulse inhibition of startle are blocked by prazosin, an alpha-1 noradrenergic antagonist
9. Multiple limbic regions mediate the disruption of prepulse inhibition produced in rats by the non-competitive NMDA antagonist dizocilpine
10. Ontogeny of isolation rearing-induced deficits in sensorimotor gating in rats
11. Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response
12. A comparison of the effects of amphetamine, strychnine and caffeine on prepulse inhibition and latent inhibition
13. Reversal of isolation rearing-induced deficits in prepulse inhibition by Seroquel and olanzapine
14. Disruption of prepulse inhibition and increases in locomotor activity by competitive N-methyl-D-aspartate receptor antagonists in rats
15. Pharmacological characterization of MDL 105,519, an NMDA receptor glycine site antagonist
16. Effects of MK801 and neuroleptics on prepulse inhibition: Re-examination in two strains of rats
17. Enhanced neurotensin neurotransmission is involved in the clinically relevant behavioral effects of antipsychotic drugs: Evidence from animal models of sensorimotor gating
18. Sensorimotor gating and schizophrenia: Human and animal model studies
19. Prestimulus effects on human startle reflex in normals and schizophrenics
20. Gating and habituation of the startle reflex in schizophrenic patients
21. Human studies of prepulse inhibition of startle: Normal subjects, patient groups, and pharmacological studies
22. The glycine/NMDA receptor antagonist, L-701,324 reverses isolation-induced deficits in prepulse inhibition in the rat
23. 3 receptor agonist, +-PD 128907, in the rat
24. 4 receptor antagonist, does not exhibit a neuroleptic-like profile in rodent behavioral tests
25. Effects of the novel antipsychotic ziprasidone on drug-disrupted prepulse inhibition in the rat
26. The disruptive effects of cocaine on prepulse inhibition is prevented by repeated administration in rats
27. 2 dopamine receptor agonists and antagonists on prepulse inhibition of acoustic startle in the rat
28. Prepulse inhibition of the acoustic startle reflex using visual and auditory prepulses: Disruption by apomorphine
29. Disruption in prepulse inhibition after alpha-1 adrenoceptor stimulation in rats
30. Sensorimotor gating in boys with Tourette's syndrome and ADHD: Preliminary results
31. Long-term evaluation of isolation-rearing induced prepulse inhibition deficits in rats
32. NPC 16377, a potent and selective sigma-ligand. II. Behavioral and neuroprotective profile
33. Effects of chronic low-level oral lead exposure on prepulse inhibition of acostic startle in the rat
34. Effects of phencyclidine PCP and+MK-801 on sensorimotor gating in CD-1 mice
35. Effect of nicotine, lo-beline, and mecamylamine on sensory gating in the rat
36. Apomorphine, d-amphetamine, strychnine and yohimbine do not alter prepulse inhibition of the acoustic startle reflex
37. Apomorphine disrupts the inhibition of acoustic startle induced by weak prepulses in rats
38. Differential effects of ketamine on gating of auditory evoked potentials and prepulse inhibition in rats
39. Potentiation of prepulse inhibition of the startle reflex in rats: Pharmacological evaluation of the procedure as a model for detecting antipsychotic activity
40. Some, but not all, antipsychotic drugs potentiate a low level of prepulse inhibition shown by rats of the Wistar strain
41. Prepulse inhibition of the startle reflex in rats: Effects of compounds acting at various sites on the NMDA receptor complex
42. The disruption of prepulse inhibition by social isolation in the Wistar rat: How robust is the effect?
43. Abnormal mental states induced by phencyclidine as a model of schizophrenia
44. Lack of sensitization to the effects ofd-amphetamine and apomorphine on sensori-motor gating in rats
45. Psychopharmacology of prepulse inhibition in mice
46. 1B mice
47. 1B knockout mice
48. Knockout mice reveal opposite roles for serotonin 1A and 1B receptors in prepulse inhibition
49. Clinical and sensorimotor gating effects of ketamine in normals
50. Subchronically applied phencyclidine fails to disrupt prepulse inhibition in rats
51. The long-term effects of maternal deprivation depend on the genetic background
52. The effects of an early stressful life event on sensorimotor gating in adult rats
53. Sensory gating in rats: Lack of correlation between auditory evoked potential gating and prepulse inhibition
54. Nicotine administration impairs sensory gating in Long-Evans rats
55. Effects of nicotine and stress on startle amplitude and sensory gating depend on rat strain and sex
56. Individual differences in prepulse inhibition of startle as a measure of individual dopamine function
57. Cysteamine blocks amphetamine-induced deficits in sensorimotor gating
58. The effects of subchronic haloperidol on intact and dizocilpine-disrupted sensorimotor gating
59. Oxytocin modulates psychotomimetic-induced deficits in sensorimotor gating
60. Antipsychotic potential of CCK-based treatments: An assessment using the prepulse inhibition model of psychosis
61. Novel antipsychotic-like effects on prepulse inhibition of startle produced by a neurotensin agonist
62. Developmental stress disrupts habituation but spares prepulse inhibition in young rats
63. 1A antagonist WAY 100135
64. Competitive NMDA and strychnine-insensitive glycine-site antagonists disrupt prepulse inhibition
65. Differential effects of the strychnine-insensitive glycine site antagonist (+)HA-966 on the hyperactivity and the disruption of prepulse inhibition induced by phencyclidine in rats
66. Competitive NMDA receptor antagonists disrupt prepulse inhibition without reduction of startle amplitude in a dopamine receptor-independent manner in mice
67. PCP (phencyclidine): An update
68. Animal models of psychiatric disorders
69. Animal models relevant to schizophrenia disorders
70. Measurement of startle response, prepulse inhibition, and habituation
71. Effects of apomorphine and amphetamine on patterns of locomotor and investigatory behavior in rats
72. Startle response models of sensorimotor gating and habituation deficits in schizophrenia
73. Isolation rearing of rats produces a deficit in prepulse inhibition of acoustic startle similar to that in schizophrenia
74. The effects of M100907 in pharmacological and developmental animal models of prepulse inhibition deficits in schizophrenia
75. Effects of LU-111995 in three models of disrupted prepulse inhibition in rats
76. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter
77. Effects of the hallucinogen psilocybin on habituation and prepulse inhibition of the startle reflex in humans
78. Structural and functional abnormalities of the hippocampal formation in rats with environmentally induced reductions in prepulse inhibition of acoustic startle
79. Effects of isolation-rearing on acoustic startle and prepulse inhibition in Wistar and fawn hooded rats
80. Localizing haloperidol effects on sensorimotor gating in a predictive model of antipsychotic potency
81. Effects of pyrethroids on the acoustic startle reflex in the rat
82. Effects of subchronic d-amphetamine on prepulse and gap inhibition of the acoustic startle reflex in rats
83. 2 dopamine receptor antagonists reverse prepulse inhibition deficits in an animal model of schizophrenia
84. The effects of haloperidol and clozapine on the disruption of sensorimotor gating induced by the noncompetitive glutamate antagonist MK-801
85. 1-noradrenergic receptor antagonist, has no effect on symptoms but increases autonomic arousal in schizophrenic subjects
86. Effects of prenatal exposure to toluene on postnatal development and behavior in rats
87. Effect of d-amphetamine on prepulse inhibition of the startle reflex in humans
88. Effects of phencyclidine on prepulse inhibition of acoustic startle response in the macaque
89. Mechanisms of phencyclidine (PCP)-N-methyl-D-aspartate (NMDA) receptor interaction: Implications for schizophrenia
90. Recent advances in the phencyclidine model of schizophrenia
91. The atypical antipsychotic, remoxipride, blocks phencyclidine-induced disruption of prepulse inhibition in the rat
92. Prepulse inhibition of acoustic startle, a measure of sensorimotor gating: Effects of antipsychotics and other agents in rats
93. Nitric oxide synthase inhibition blocks phencyclidine-induced behavioural effects on prepulse inhibition and locomotor activity in the rat
94. The neuronal selective nitric oxide inhibitor AR-R 17477, blocks some effects of phencyclidine, while having no observable behavioural effects when given alone
95. Effects of scopolamine in comparison with apomorphine and phencyclidine on prepulse inhibition in rats
96. Muscarinic cholinergic modulation of prepulse inhibition of the acoustic startle reflex
97. B site in rat models for antipsychotic-like activity
98. The effect of ketamine on prepulse inhibition and attention
99. 5-HT modulation of auditory and visual sensorimotor gating: I. Effects of 5-HT releasers on sound and light prepulse inhibition in Wistar rats
100. Failure of haloperidol to block the effects of phencyclidine and dizocilpine on acoustic startle prepulse inhibition
101. Rat strain differences in the ability to disrupt sensorimotor gating are limited to the dopaminergic system, specific to prepulse inhibition, and unrelated to changes in startle amplitude or nucleus accumbens dopamine receptor sensitivity
102. Sensorimotor gating changes across the estrous cycle in female rats
103. Regulation of sensorimotor gating by interactions of dopamine and adenosine in the rat
104. Mitochondrial toxin 3-nitropropionic acid produces startle reflex abnormalities and striatal damage in rats that model some features of Huntington's disease
105. Post-weaning handling attenuates isolation-rearing induced disruptions of prepulse inhibition in rats
106. ACEA 1021, a glycine site antagonist with minor psychotomimetic and amnestic effects in rats
107. Subanesthetic doses of ketamine stimulate psychosis in schizophrenia
108. Lack of effect of an early stressful life event on sensorimotor gating in adult rats
109. Long-term effects of prenatal stress experience and postnatal maternal separation on emotionality and attentional processes
110. Spatial and temporal patterning distinguishes the locomotor activating effects of dizocilpine and phencyclidine in rats
111. Multisensory deficits in rats produced by acute exposure to cold swim stress
112. Effects of MDMA (Ecstasy) on prepulse inhibition and habituation of startle in humans after pretreatment with citalopram, haloperidol, or ketanserin
113. Behavioral effects of chronic phencyclidine in monkeys
114. Study of a new schizophrenomimetic drug-Sernyl
115. Model psychoses and schizophrenia
116. Clozapine blunts N-methyl-D-aspartate antagonist-induced psychosis: A study with ketamine
117. Effects of NMDA receptor ligands on sensorimotor gating in the rat
118. Effects of phencyclidine and phencyclidine biologs on sensorimotor gating in the rat
119. Parametric determinants in pre-stimulus modification of acoustic startle: Interaction with ketamine
120. Dopaminergic stimulation disrupts sensorimotor gating in the rat
121. Prepulse inhibition of the acoustic startle response is disrupted byN-ethyl-3,4-methylenedioxyamphetamine MDEA in the rat
122. Effects of the cannabinoid CB1 receptor antagonist SR141716A on the behavior of pigeons and rats
123. 4 receptor antagonists reverse apomorphine-induced blockade of prepulse inhibition
124. 2a receptor antagonist M100907 in a mouse model of schizophrenia is counteracted by ritanserin
125. 2C receptor antagonist treatment?
126. Characterization of the disruptions of prepulse inhibition and habituation of startle induced by alpha-ethyltryptamine
127. Effects of sustained cocaine exposure on sensorimotor gating of startle in rats
128. Effects of sustained phencyclidine exposure on sensorimotor gating of startle in rats
129. Ontogeny of phencyclidine and apomorphine-induced startle gating deficits in rats
130. "Early" and "late" effects of sustained haloperidol on apomorphine- and phencyclidine-induced sensorimotor gating deficits
131. Disorders of attention and perception in early schizophrenia
132. Role of serotonin in the action of atypical antipsychotic drugs
133. Treatment of schizophrenia and spectrum disorders: Pharmacotherapy, psychosocial treatments, and neurotransmitter interactions
134. Dissociation between startle and prepulse inhibition in rats exposed to gamma radiation at day 15 of embryogeny
135. Recent basic findings in support of excitatory amino acid hypotheses of schizophrenia
136. Sensory gating deficits in rats with early disruption of limbic cortical development: Relevance to schizophrenia
137. 1A receptors in the modulation of the acoustic startle reflex in rats
138. 4 receptor antagonist, NRA0160: A preclinical neuropharmacological profile
139. Amphetamine sensitivity in open-field activity vs. the prepulse inhibition paradigm
140. Drug-induced potentiation of prepulse inhibition of acoustic startle reflex in mice: A model for detecting antipsychotic activity
141. 2A antagonist MDL 100,907 on disruption of sound and light prepulse inhibition produced by 5-HT agonists in Wistar rats
142. 2 dopamine receptor agonist disrupts sensorimotor gating in rats. Implications for dopaminergic abnormalities in schizophrenia
143. Chronic treatment with haloperidol diminishes the phencyclidine-induced sensorimotor gating deficit in rats
144. Prenatal exposure to nicotine: Effects on prepulse inhibition and central nicotinic receptors
145. 4 receptor subtype is essential for the disruption of prepulse inhibition produced by amphetamine in mice
146. 2 receptor antagonists
147. Strain-specific effects of amphetamine on prepulse inhibition and patterns of locomotor behavior in mice
148. The novel atypical antipsychotic olanzapine, but not the CCK-B antagonist LY288513, blocks apomorphine-induced disruption of prepulse inhibition
149. Responding to acoustic startle during chronic ethanol intoxication and withdrawal
150. Pharmacological actions of a novel, high-affinity, and selective human dopamine D(3) receptor antagonist, SB-277011-A
151. Differential effects of apomorphine on prepulse inhibition of acoustic startle reflex in two rat strains
152. Prepulse inhibition as a screening test for potential antipsychotics
153. 5-Hydroxytryptamine 1A receptor agonists block prepulse inhibition of acoustic startle reflex
154. Neonatal cytomegalovirus exposure decreases prepulse inhibition in adult rats: Implications for schizophrenia
155. 2C-receptors modulate the acoustic startle reflex, prepulse inhibition, and aggression in mice
156. LY354740 affects startle responding but not sensorimotor gating or discriminative effects of phencyclidine
157. Effects of haloperidol and SCH 23390 on acoustic startle and prepulse inhibition under basal and stimulated conditions
158. Effects of acute systemic 3-nitroproprionic acid administration on rat activity and acoustic startle
159. Amphetamine dose dependently disrupts prepulse inhibition of the acoustic startle response in rats within a narrow time window
160. Multiple serotonin receptor subtypes modulate prepulse inhibition of the startle response in rats
161. 8-OH-DPAT disruption of prepulse inhibition in rats: Reversal with (+)WAY 100,135 and localization of site of action
162. 2C receptors
163. 1D receptors in the modulation of prepulse inhibition of startle
164. 2A receptors in the ventral pallidum
165. Behavioral effects of 8-OH-DPAT in chronically stressed male and female rats
166. Psychotogenic drugs as models for schizophrenia
167. Clozapine and haloperidol in an animal model of sensorimotor gating deficits in schizophrenia
168. Central dopamine hyperactivity in rats mimics abnormal acoustic startle response in schizophrenics
169. Opiate-dopamine interactions in the neural substrates of acoustic startle gating in the rat
170. Effects of spiperone, raclopride, SCH 23390 and clozapine on apomorphine inhibition of sensorimotor gating of the startle response in the rat
171. A preliminary assessment of sensorimotor gating in patients with obsessive compulsive disorder
172. Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients
173. Seroquel (ICI 204,636) restores prepulse inhibition of acoustic startle in apomorphine-treated rats: Similarities to clozapine
174. Impaired prepulse inhibition of acoustic and tactile startle response in patients with Huntington's disease
175. Seroquel restores sensorimotor gating in phencyclidine-treated rats
176. Seroquel, clozapine and chlorpromazine restore sensorimotor gating in ketamine-treated rats
177. Towards a cross-species pharmacology of sensorimotor gating: Effects of amantadine, bromocriptine, pergolide and ropinirole on prepulse inhibition of acoustic startle in rats
178. Discrepant findings of clozapine effects on prepulse inhibition of startle: Is it the route or the rat?
179. Toward understanding the biology of a complex phenotype: Rat strain and substrain differences in the sensorimotor gating-disruptive effects of dopamine agonists
180. Neural circuit regulation of prepulse inhibition of startle in the rat: Current knowledge and future challenges
181. Methylazoxymethanol acetate-induced abnormalities in the entorhinal cortex of the rat; parallels with morphological findings in schizophrenia
182. Effects of single and repeated exposure to apomorphine on the acoustic startle reflex and its inhibition by a visual prepulse
183. High doses of aspartame have no effects on sensorimotor function or learning and memory in rats
184. The effects of low dose ketamine on sensory gating, neuroendocrine secretion and behavior in healthy human subjects
185. Effects of isolation rearing on startle reactivity, habituation, and prepulse inhibition in male Lewis, Sprague-Dawley, and Fischer F344 rats
186. Examination of drug-induced and isolation-induced disruptions of prepulse inhibition as models to screen antipsychotic drugs
187. 2 receptor antagonist ketanserin
188. 3 receptors?
189. 2A receptor antagonist and putative antipsychotic, blocks dizocilpine-induced prepulse inhibition deficits in Sprague-Dawley and Wistar rats
190. Is there a critical development "window" for isolation rearing-induced changes in prepulse inhibition of the acoustic startle response?
191. Environmental enrichment and isolation rearing in the rat: Effects on locomotor behavior and startle response plasticity
192. The effect of auditory and visual stimulation on the skin potential responses of schizophrenics
193. Opposite effects of 3,4-methylenedioxymethamphetamine (MDMA) on sensorimotor gating in rats versus healthy humans
194. Long-term effects of prenatal phenytoin exposure on offspring behavior in rats
195. Neonatal methamphetamine-induced long-term acoustic startle facilitation in rats as a function of prepulse stimulus intensity
196. Antipsychoticlike effects of amoxapine, without catelpsy, using the prepulse inhibition of the acoustic startle reflex test in rats
197. 2 interactions regulate prepulse inhibition in rats?
198. A hyperglycinergic rat model for the pathogenesis of schizophrenia: Preliminary findings
199. Differential effects of CGP 37849 and MK-801, competitive and noncom-petitive NMDA antagonists, with respect to the modulation of sensorimotor gating and dopamine outflow in the prefrontal cortex of rats
200. Environmental animal models for sensorimotor gating deficiencies in schizophrenia: A review
201. Circadian time does not modify the prepulse inhibition response or its attenuation by apomorphine
202. Isolation rearing-induced disruption of prepulse inhibition: Further evidence for fragility of the response
203. Strain differences in the isolation-induced effects on prepulse inhibition of the acoustic startle response and on locomotor activity
204. Clozapine's effects on phencyclidine-induced disruption of prepulse inhibition of the acoustic startle response
205. Nitric oxide synthase inhibitors attenuate phencyclidine-induced disruption of prepulse inhibition
206. Effects of modulation of nitric oxide on acoustic startle responding and prepulse inhibition in rats
207. Social isolation in the rat produces developmentally specific deficits in prepulse inhibition of the acoustic startle response without disrupting latent inhibition
208. Buspirone: A potential atypical neuroleptic
209. Cholinergic mechanisms in startle and prepulse inhibition: Effects of the false cholinergic precursor N-aminodeanol
210. Involvement of serotonin 2A receptors in phencyclidine-induced disruption of prepulse inhibition of the acoustic startle in rats
211. Dose and time response analysis of apomorphine's effect on prepulse inhibition of acoustic startle
212. (-)Alprenolol potentiates the disrupting effects of dizocilpine on sensorimotor function in the rat
213. Repeated administration of amphetamine induces sensitisation to its disruptive effect on prepulse inhibition in the rat
214. Role of dopamine in prepulse inhibition of acoustic startle
215. Prenatal heroin exposure effects on development, acoustic startle response, and locomotion in weanling rats